SLU-PP-332 has no human dose, and it is important to be blunt about why: it has never been tested in humans. It is a preclinical small-molecule ERR agonist, and all of its exercise-mimetic and metabolic findings come from mouse studies where it was given orally.[1][2]
Reviewed for accuracy · Last reviewed July 7, 2026Any specific dose figure circulated online is extrapolation from that animal research, not a validated human regimen. Because it is an early-stage research compound rather than an approved drug or even a clinical-stage one, there is no basis for a human dose, and product identity and purity from research-chemical suppliers are additional unknowns.
This page is an independent educational reference and is not medical advice, and does not indicate any approval status for any use. SLU-PP-332 is a preclinical compound not tested in humans.